Dr Gabi Suess is one of Ozgene's co-founders and chief scientific officer. She is mostly involved with Ozgene’s intensive research & development programs. These efforts result in establishing novel technologies to develop and investigate genetically modified mouse models. Dr Suess received her PhD from the University of Basel, Switzerland. She has held research appointments at Roche Pharmaceuticals in Basel, the Max-Planck-Institute for Immunobiology, in Freiburg, Germany and at the Walter and Eliza Hall Institute for Medical Research in Melbourne, Australia. Dr Suess is an immunologist by training and has been involved in the generation and analysis of genetically modified mouse models for over 25 years.